Search results
12 kwi 2024 · CDC considers methicillin-resistant Staphylococcus aureus (MRSA) a "serious threat." 1 In healthcare facilities, such as hospitals or nursing homes, MRSA can cause severe problems including: Bloodstream infections. Pneumonia.
14 lis 2022 · Due to the increasing number of cases of resistance or therapeutic failure to first-line antibiotics, physicians have started to look for other alternatives. Among these alternatives, β-lactams, especially ceftaroline, have shown promise to be an integral part of the future MRSA treatment protocol.
11 kwi 2024 · Complications. MRSA infections can cause serious problems in and outside of healthcare settings, including: Pneumonia (lung infections). Bloodstream infections. Surgical site infections. Sepsis, the body's extreme response to an infection (if left untreated).
18 mar 2011 · Clinicians often struggle with how best to treat MRSA, resulting in wide variations in approaches to therapy. The growing clinical impact of MRSA, particularly community-acquired infections, prompted the Infectious Diseases Society of America to develop its first treatment guidelines for MRSA.
12 kwi 2024 · CDC recommends the use of Contact Precautions in inpatient acute care settings for patients colonized or infected with MDROs, including MRSA. In 2022, the United States showed progress in preventing several important healthcare-associated infections (HAIs) in acute care hospitals (ACHs).
13 kwi 2023 · Vancomycin remains the mainstay of therapy for most invasive MRSA infections. However, the choice of antibiotic used in the clinical setting can depend on many factors: resistance patterns, site of infection, age and geographical location of the patient, side effects and availability of antibiotics.
8 lut 2019 · Recent examples of emergent MRSA strains include the health-care-associated MRSA (HA-MRSA) clonal complex 30 (CC30) in North America and Europe, community-associated MRSA (CA-MRSA)...
